Company / Shareholders' Equity
ORTHOPEDIATRICS CORP Shareholders' Equity History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$354.6M
FY2025
5-year range
$142.4M / $378.6M
FY2021-FY2025
Trend
-6.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 9 years, ranging from -$65M in FY2018 to $379M in FY2024.
Based on SEC 10-K filings.
$355M in FY2025 with a 5-year CAGR of +34.1%.
Improved from $225M to $355M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +14.7%
- 5-Year CAGR
- +34.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +34.1%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 6.4% year-over-year.
- Peak shareholders' equity was recorded in FY2024.
- Lowest shareholders' equity in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $354.6M | -6.4% |
| FY2024 | $378.6M | +68.0% |
| FY2023 | $225.4M | -4.0% |
| FY2022 | $234.8M | +64.9% |
| FY2021 | $142.4M | +74.2% |
| FY2020 | $81.7M | +72.1% |
| FY2019 | $47.5M | +172.7% |
| FY2018 | -$65.3M | -20.7% |
| FY2017 | -$54.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026